| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 919.51M | 1.04B | 1.19B | 1.19B | 1.37B |
| Gross Profit | 368.26M | 462.31M | 511.63M | 506.99M | 628.84M |
| EBITDA | 61.96M | 148.51M | 151.29M | 1.45M | 294.89M |
| Net Income | 29.82M | 27.41M | 20.81M | -85.12M | 164.19M |
Balance Sheet | |||||
| Total Assets | 1.96B | 2.09B | 2.23B | 2.20B | 2.47B |
| Cash, Cash Equivalents and Short-Term Investments | 505.15M | 476.03M | 448.65M | 357.78M | 536.67M |
| Total Debt | 397.52M | 241.35M | 369.48M | 317.17M | 292.75M |
| Total Liabilities | 608.49M | 749.20M | 892.51M | 871.60M | 1.04B |
| Stockholders Equity | 1.35B | 1.34B | 1.32B | 1.30B | 1.41B |
Cash Flow | |||||
| Free Cash Flow | -13.20M | 145.76M | 64.06M | -177.51M | -74.31M |
| Operating Cash Flow | -2.77M | 154.39M | 95.90M | -89.95M | -3.71M |
| Investing Cash Flow | 42.86M | 43.38M | -121.28M | 110.32M | -84.68M |
| Financing Cash Flow | -34.63M | -159.43M | 12.61M | -59.88M | -188.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$1.00B | 7.27 | 24.21% | 6.76% | 7.12% | 28.89% | |
71 Outperform | HK$837.50M | 7.09 | 19.46% | 8.89% | -8.00% | -11.37% | |
65 Neutral | HK$649.18M | 7.56 | 24.23% | ― | 21.10% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$1.77B | 2.40 | 2.58% | 9.71% | -7.47% | -33.28% | |
49 Neutral | HK$882.54M | 29.60 | 2.26% | 1.28% | -14.05% | 20.05% | |
46 Neutral | HK$857.52M | 10.31 | 1.70% | 1.90% | -7.20% | -55.24% |